These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8524505)

  • 1. Hepatitis C virus infection in haemodialysis patients: lessons from epidemiology and prophylaxis.
    Loureiro A; Macedo G; Pinto T
    Nephrol Dial Transplant; 1995; 10 Suppl 6():83-7. PubMed ID: 8524505
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus in the haemodialysis units: novel insights by new techniques?
    Fabrizi F; Locatelli F
    Nephrol Dial Transplant; 1999 May; 14(5):1072-5. PubMed ID: 10344338
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya.
    Elzouki AN; Bushala M; Tobji RS; Khfaifi M
    Nephrol Dial Transplant; 1995; 10(4):475-6. PubMed ID: 7542751
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C virus infection in haemodialysis patients.
    Gilli P; Storari A
    Nephrol Dial Transplant; 1992; 7(12):1259-60. PubMed ID: 1283448
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units.
    dos Santos JP; Loureiro A; Cendoroglo Neto M; Pereira BJ
    Nephrol Dial Transplant; 1996 Oct; 11(10):2017-22. PubMed ID: 8918716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of universal precautions in limiting nosocomial transmission of hepatitis C virus in haemodialysis units.
    Aucella F; Del Giudice AM; Scarlatella A; Di Tullio MD; Centra M; Di Giorgio GD; Stallone C
    Int J Artif Organs; 1996 Jul; 19(7):435-6. PubMed ID: 8841859
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at kidney centre in a tertiary health facility in Maiduguri, Nigeria.
    Ummate I; Denue BA; Kida IM; Ohioma OJ; Baba DB; Goni W
    Pan Afr Med J; 2014; 19():305. PubMed ID: 25883732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of anti-HCV among haemodialysis patients in Turkey: a multicentre study.
    Akpolat T; Arik N; Günaydin M; Utaş C; Dilek K; Caglar S; Candan F; Süleymanlar G; Paydaş S; Sen S
    Nephrol Dial Transplant; 1995; 10(4):479-80. PubMed ID: 7542753
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiology and prevention of HCV infection in dialysis centers].
    Cialdea L; Sagliocca L; Mele A
    Ann Ist Super Sanita; 1995; 31(3):313-5. PubMed ID: 8712574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and mechanisms of transmission of the hepatitis C virus in haemodialysis.
    Jadoul M
    Nephrol Dial Transplant; 2000; 15 Suppl 8():39-41. PubMed ID: 11261702
    [No Abstract]   [Full Text] [Related]  

  • 11. IgM antibodies to hepatitis C virus and haemodialysis patients.
    Navarro JF; Teruel J; Mateos M; Ortuño J
    Nephrol Dial Transplant; 1994; 9(8):1211. PubMed ID: 7528362
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus outbreak in a haemodialysis unit: learning from failures.
    Senatore S; Galli C; Conti A; Faccini M; Cantoni S; Ciconali G; Mainardi G; Lamberti A; Dighera R; Radice Trolli F; Oggioni C; Angelini Sironi L; Cozzolino M; Zanetti AR; Romanò L
    J Hosp Infect; 2016 Nov; 94(3):249-252. PubMed ID: 27613441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of chronic hepatitis C virus infection in patients on maintenance haemodialysis.
    Ozyilkan E; Akpolat T; Arik N; Köseoglu HT; Telatar H
    Nephrol Dial Transplant; 1994; 9(11):1697-8. PubMed ID: 7532840
    [No Abstract]   [Full Text] [Related]  

  • 15. An archived serum sample as a clue for identifying the primary source of a nosocomial hepatitis C virus outbreak in a haemodialysis unit.
    Szücs M; Dencs Á; Varga E; Balajcza BB; Kiss G; Reuter G; Csiky B; Sándor J; Takács M
    Arch Virol; 2014 Sep; 159(9):2207-12. PubMed ID: 24728952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Holiday haemodialysis and imported hepatitis C virus infection: a series of sixteen cases in two large haemodialysis units.
    Bhattacharya S; Price N; Boxall E; Adu D; Lipkin G; Smith S; Osman H
    J Clin Virol; 2009 Aug; 45(4):296-9. PubMed ID: 19451020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit.
    Forns X; Fernández-Llama P; Pons M; Costa J; Ampurdanés S; López-Labrador FX; Olmedo E; López-Pedret J; Darnell A; Revert L; Sánchez-Tapias JM; Rodés J
    Nephrol Dial Transplant; 1997 Apr; 12(4):736-40. PubMed ID: 9141004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HCV prevalence, viraemic status and genotype distribution in an Italian haemodialysis population.
    Beccari M; Tagger A; Romagnoni M; Rizzolo L; Veneroni G; Sorgato G
    Nephrol Dial Transplant; 1996 May; 11(5):907-8. PubMed ID: 8671927
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region.
    Di Napoli A; Pezzotti P; Di Lallo D; Petrosillo N; Trivelloni C; Di Giulio S;
    Am J Kidney Dis; 2006 Oct; 48(4):629-37. PubMed ID: 16997059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of hepatitis C virus antibodies in hemodialysis patients.
    Machida J; Yamaguchi K; Ueda S; Yoshida M; Kusumoto Y; Nishimura Y; Futami G; Ishii T; Watanabe T; Takatsuki K
    Nephron; 1992; 60(1):117-8. PubMed ID: 1310800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.